7th Annual USC Multi-Disciplinary Breast Cancer Symposium


 

New Data Show Pertuzumab + Trastuzumab + Chemo Continue Yielding Clinical Benefit / Adjuvant T-DM1 Benefit in HER2+ Early BC

1,187 views
February 25, 2020
Comments 0
Login to view comments. Click here to Login